BACKGROUND: Rate of decline in 6-L-[(18)F]fluorodopa (FDOPA) uptake within the striatum has been reported as showing regional differences in Parkinson's disease (PD). METHODS: We acquired longitudinal brain FDOPA positron emission tomography (PET) studies in 26 PD subjects and 11 controls over 4.5 years. We analyzed both spatially normalized voxel-wise maps of radiotracer influx (Kocc) and average Kocc values for six non-overlapping volumes of interest (VOIs) encompassing the striatum. RESULTS: The voxel-wise analysis showed that in PD, FDOPA Kocc decline spanned the striatum but was greatest in the posterior putamen ipsilateral and anterior putamen contralateral to initial symptoms. The VOI approached showed that absolute rates of Kocc decline were significantly greater in PD than control subjects, but that the slope of decline did not differ between subregions. In PD, ratios of uptake between subregions did not change during the study with the exception of the ipsilateral putamen/caudate ratio. Decline rates were marginally greater during earlier time segments. Both male gender and advancing age were associated with lower baseline FDOPA uptake, but no difference in decline rates. VOI Kocc values were significantly correlated with disease duration, but only moderately correlated with clinical measures. DISCUSSION: We conclude that FDOPA uptake in subregions of the striatum is strongly correlated with disease duration and age, and declines approximately equally from symptom onset in PD. This implies that in idiopathic PD, relative preservation of uptake in the anterior striatum reflects a delay in pathologic involvement of nigrostriatal projections to this region.
BACKGROUND: Rate of decline in 6-L-[(18)F]fluorodopa (FDOPA) uptake within the striatum has been reported as showing regional differences in Parkinson's disease (PD). METHODS: We acquired longitudinal brain FDOPA positron emission tomography (PET) studies in 26 PD subjects and 11 controls over 4.5 years. We analyzed both spatially normalized voxel-wise maps of radiotracer influx (Kocc) and average Kocc values for six non-overlapping volumes of interest (VOIs) encompassing the striatum. RESULTS: The voxel-wise analysis showed that in PD, FDOPA Kocc decline spanned the striatum but was greatest in the posterior putamen ipsilateral and anterior putamen contralateral to initial symptoms. The VOI approached showed that absolute rates of Kocc decline were significantly greater in PD than control subjects, but that the slope of decline did not differ between subregions. In PD, ratios of uptake between subregions did not change during the study with the exception of the ipsilateral putamen/caudate ratio. Decline rates were marginally greater during earlier time segments. Both male gender and advancing age were associated with lower baseline FDOPA uptake, but no difference in decline rates. VOI Kocc values were significantly correlated with disease duration, but only moderately correlated with clinical measures. DISCUSSION: We conclude that FDOPA uptake in subregions of the striatum is strongly correlated with disease duration and age, and declines approximately equally from symptom onset in PD. This implies that in idiopathic PD, relative preservation of uptake in the anterior striatum reflects a delay in pathologic involvement of nigrostriatal projections to this region.
Authors: Elina Nurmi; Jörgen Bergman; Olli Eskola; Olof Solin; Tero Vahlberg; Pirkko Sonninen; Juha O Rinne Journal: Synapse Date: 2003-06-01 Impact factor: 2.562
Authors: Alan L Whone; Ray L Watts; A Jon Stoessl; Margaret Davis; Sven Reske; Claude Nahmias; Anthony E Lang; Olivier Rascol; Maria J Ribeiro; Philippe Remy; Werner H Poewe; Robert A Hauser; David J Brooks Journal: Ann Neurol Date: 2003-07 Impact factor: 10.422
Authors: Vesna Sossi; Raúl de la Fuente-Fernández; James E Holden; Michael Schulzer; Thomas J Ruth; Jon Stoessl Journal: J Cereb Blood Flow Metab Date: 2004-08 Impact factor: 6.200
Authors: Susan R Criswell; Susan Searles Nielsen; Mark Warden; Joel S Perlmutter; Stephen M Moerlein; Hubert P Flores; John Huang; Lianne Sheppard; Noah Seixas; Harvey Checkoway; Brad A Racette Journal: Neurotoxicology Date: 2017-07-08 Impact factor: 4.294
Authors: Catherine L Gallagher; Brian Bell; Matthew Palotti; Jen Oh; Bradley T Christian; Ozioma Okonkwo; Jitka Sojkova; Laura Buyan-Dent; Robert J Nickles; Sandra J Harding; Charles K Stone; Sterling C Johnson; James E Holden Journal: Brain Imaging Behav Date: 2015-12 Impact factor: 3.978
Authors: Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth Journal: J Neurochem Date: 2021-10-03 Impact factor: 5.546
Authors: José A Pineda-Pardo; Álvaro Sánchez-Ferro; Mariana H G Monje; Nicola Pavese; José A Obeso Journal: Brain Date: 2022-04-29 Impact factor: 15.255
Authors: Daniel P Eisenberg; Grisel Lopez; Michael D Gregory; Karen F Berman; Ellen Sidransky Journal: Mov Disord Date: 2021-11-11 Impact factor: 9.698
Authors: Sinn-Rithy Toch; Sylvain Poussier; Emilien Micard; Marc Bertaux; Axel Van Der Gucht; Elodie Chevalier; Pierre-Yves Marie; Eric Guedj; Antoine Verger Journal: Mol Imaging Biol Date: 2019-06 Impact factor: 3.488